GlassScriptPhysician profile
Keith Robert Berend
NPI 1003809484
$4,594,580.90
in general payments reported to CMS, 2019-2025
13 companies · $77K in 2025
The $77K reported for 2025 was more than what 91% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $983K · 2020: $841K · 2021: $2.3M · 2022: $54K · 2023: $71K · 2024: $269K · 2025: $77K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $412K · Travel and Lodging: $3,182 · Food and Beverage: $1,961.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $412,000.00 |
| Travel and Lodging | $3,181.55 |
| Food and Beverage | $1,961.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $4,120,685.92 | 2019-2025 | Rosa, Oxford |
| Medacta USA, INC. | $416,735.78 | 2021-2025 | Gmk Sphere, Primary Shoulder, Myknee |
| Smith+Nephew, INC. | $42,542.35 | 2022 | |
| Cardinal Health 200 LLC | $11,550.00 | 2024-2025 | |
| Engage Uni, LLC | $1,614.00 | 2021 | |
| Total Joint Orthopedics, INC. | $1,146.63 | 2019 | |
| Becton, Dickinson and Company | $147.21 | 2022 | |
| Davol INC. | $95.18 | 2021-2022 | |
| Ethicon US, LLC | $20.45 | 2019 | |
| Si-Bone, INC. | $17.87 | 2023 | |
| Vericel Corporation | $16.78 | 2024 | Maci |
| Spr Therapeutics, INC | $8.73 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,358,576.20 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Berend listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.